US-Based Scientific Journals: Leading Publications and Their Scope
The United States is home to some of the most-cited and widely read scientific journals in the world, spanning disciplines from molecular biology to astrophysics. This page maps the landscape of major US-based publications — what each covers, who publishes it, and how to think about their relative scope and authority. Understanding where a study appeared tells a researcher almost as much as the study itself.
Definition and scope
A US-based scientific journal is a refereed periodical whose editorial headquarters, owning society, or primary publisher is domiciled in the United States — even if, as is common with major publishers, content is distributed globally and peer reviewers are drawn from dozens of countries. This distinction matters for policy reasons: the 2022 OSTP memo on public access directing federal agencies to require immediate open access for federally funded research applies specifically to US-funded work, and the journals that publish most of that work are concentrated in a relatively small set of American learned societies and publishers.
The scope of individual journals varies enormously. At one extreme sit broad multidisciplinary flagships — publications designed to publish the most significant findings across all of science. At the other are highly specialized titles covering a single technique or niche organism. The overview of multidisciplinary journals and the discipline-by-discipline breakdown cover those contrasts in depth.
How it works
Major US-based journals operate through one of three organizational models:
-
Learned society journals — Published directly by a professional organization, with editorial governance tied to the society's membership. Examples include PNAS (Proceedings of the National Academy of Sciences), published by the National Academy of Sciences, and Science, published by the American Association for the Advancement of Science (AAAS). Revenue flows back to the society's mission rather than to a commercial shareholder.
-
University press journals — Published by a university's press division, such as journals under the University of Chicago Press or Johns Hopkins University Press. These carry institutional credibility and tend toward longer review timelines.
-
Commercial publisher imprints — Titles owned by large publishers with US editorial offices, including Cell Press titles (headquartered in Cambridge, MA) and the American Chemical Society's journal portfolio, which encompasses more than 60 refereed titles (ACS Publications).
Editorial governance at all three model types typically flows through a handling editor, associate editors, and a pool of peer reviewers — the process described in detail at peer review process explained. What changes is who controls the journal's strategic direction: for society journals, that's an elected board; for commercial imprints, it's an executive publishing board accountable to a publisher.
Common scenarios
A few flagship publications come up in virtually every cross-disciplinary conversation about US journals.
Science (AAAS) publishes roughly 800 research articles per year across all scientific fields, a number that reflects extremely selective acceptance. Its sister publication Science Advances handles a significantly larger volume with a broader acceptance scope, functioning as a high-quality overflow channel.
PNAS accepts submissions across biological, physical, and social sciences. Historically associated with member-communicated papers, PNAS shifted to standard direct submission in 2010, removing a pathway that had occasionally drawn criticism for bypassing typical gatekeeping. The journal now publishes more than 3,500 articles annually (PNAS author information).
Cell (Cell Press) anchors one of the most influential journal families in biomedical science. The Cell Press portfolio — including Cell, Neuron, Immunity, and Current Biology — covers molecular and cellular biology at the level where most major mechanistic discoveries in medicine appear first.
The New England Journal of Medicine (NEJM), published by the Massachusetts Medical Society since 1812, remains the highest-impact clinical medicine journal in the world by most metrics, including an impact factor that has exceeded 90 in recent calculations (Clarivate Journal Citation Reports).
JACS (Journal of the American Chemical Society), operating continuously since 1879, publishes more than 15,000 articles per year — an output that reflects chemistry's sheer volume of active research.
Decision boundaries
When evaluating a US-based journal for submission or citation, three distinctions do most of the analytical work.
Breadth vs. depth: Generalist journals (Science, PNAS) expect authors to frame findings for a cross-disciplinary audience. Specialist journals (JACS, Neuron) allow technical depth that would be impossible in a general audience context. A study advancing a specific synthetic chemistry technique belongs in JACS, not Science — regardless of how significant it is within chemistry.
Society vs. commercial: Society-owned journals typically reinvest surplus into grants, meetings, and educational programs. Researchers who prioritize mission alignment over impact factor alone sometimes weight this difference heavily, especially given ongoing debates about article processing charges and open access publishing.
Indexing and discoverability: A journal's presence in PubMed, Web of Science, and Scopus determines whether its content surfaces in standard literature searches. All major US society journals are indexed across these platforms. Newer or smaller titles may lack full indexing — a factor worth checking via journal indexing databases before submission.
The Scientific Journal Authority index organizes the broader reference landscape covering all of these dimensions, from metrics to manuscript preparation.
References
- OSTP Public Access Memo, August 2022 (White House)
- PNAS Author Information (National Academy of Sciences)
- ACS Publications Journal Portfolio (American Chemical Society)
- Clarivate Journal Citation Reports
- American Association for the Advancement of Science — Science Journal
- Massachusetts Medical Society — New England Journal of Medicine